Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM3 | P20309 | 20/20 | 0.72 |
| ▸ | ADRB2 | P07550 | 17/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4984240 | 1.00 | CHRM3 (0.72) | CHRM3ADRB2 | |
| SCHEMBL4995820 | 0.93 | CHRM3 (0.72) | CHRM3ADRB2 | |
| SCHEMBL4995831 | 0.93 | CHRM3 (0.72) | CHRM3ADRB2 | |
| SCHEMBL4996537 | 0.88 | CHRM3 (0.59) | CHRM3ADRB2 | |
| SCHEMBL4996550 | 0.88 | CHRM3 (0.59) | CHRM3ADRB2 | |
| SCHEMBL4018488 | 0.87 | CHRM3 (0.73) | CHRM3ADRB2 | |
| SCHEMBL4016062 | 0.87 | CHRM3 (0.73) | CHRM3ADRB2 | |
| SCHEMBL4986880 | 0.87 | CHRM3 (0.65) | CHRM3ADRB2 | |
| SCHEMBL4986863 | 0.87 | CHRM3 (0.65) | CHRM3ADRB2 | |
| SCHEMBL4990648 | 0.87 | CHRM3 (0.65) | CHRM3ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080090873-A1 | Sulfonamide derivatives | PFIZER INC. | 2008-04-17 | — | — | US | claimed |
| US-20080090873-A1 | Sulfonamide derivatives | PFIZER INC. | 2008-04-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090873-A1 | Sulfonamide derivatives | SULT2A1, SULT1A1, STS | CHRM3 2453/4885ADRB2 2763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.